 |
PDBsum entry 3uh4
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
|
|
|
|
|
|
|
Transferase/transferase inhibitor
|
PDB id
|
|
|
|
3uh4
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
 |
 |
 |
 |
Enzyme class 1:
|
 |
E.C.2.4.2.-
- ?????
|
|
 |
 |
 |
 |
 |
Enzyme class 2:
|
 |
E.C.2.4.2.30
- NAD(+) ADP-ribosyltransferase.
|
|
 |
 |
 |
 |
 |

Pathway:
|
 |
|
 |
 |
 |
 |
 |
Reaction:
|
 |
NAD+ + (ADP-D-ribosyl)n-acceptor = nicotinamide + (ADP-D- ribosyl)n+1-acceptor + H+
|
 |
 |
 |
 |
 |
NAD(+)
|
+
|
(ADP-D-ribosyl)n-acceptor
|
=
|
nicotinamide
Bound ligand (Het Group name = )
matches with 42.86% similarity
|
+
|
(ADP-D- ribosyl)n+1-acceptor
|
+
|
H(+)
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Note, where more than one E.C. class is given (as above), each may
correspond to a different protein domain or, in the case of polyprotein
precursors, to a different mature protein.
|
|
 |
|
Molecule diagrams generated from .mol files obtained from the
KEGG ftp site
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
|
| |
|
|
Acta Crystallogr Sect F Struct Biol Cryst Commun
68:115-118
(2012)
|
|
PubMed id:
|
|
|
|
|
| |
|
Structure of human tankyrase 1 in complex with small-molecule inhibitors PJ34 and XAV939.
|
|
C.A.Kirby,
A.Cheung,
A.Fazal,
M.D.Shultz,
T.Stams.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Literature references that cite this PDB file's key reference
|
|
 |
| |
PubMed id
|
 |
Reference
|
 |
|
|
|
 |
J.L.Riffell,
C.J.Lord,
and
A.Ashworth
(2012).
Tankyrase-targeted therapeutics: expanding opportunities in the PARP family.
|
| |
Nat Rev Drug Discov,
11,
923-936.
|
 |
|
 |
 |
|
The most recent references are shown first.
Citation data come partly from CiteXplore and partly
from an automated harvesting procedure. Note that this is likely to be
only a partial list as not all journals are covered by
either method. However, we are continually building up the citation data
so more and more references will be included with time.
|
');
}
}
 |